Tag Archives: MCRB

stock

August lean hogs are trading at 77.92, up 0.57 cents/lb. October lean hogs are trading at 65.02, up 0.72 cents /lb. December lean hogs are trading at 59.00, up 0.60 cents/lb.

Lean hog futures are trading higher just after the open Wednesday.

Market chatter about weather and cash prices is making the rounds.

The U.S. Department of Agriculture (USDA) monthly cold storage report is due out Friday at 3:00 p.m. ET.

Posted-In: lean hog futuresFutures Commodities Markets

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  Related Articles Cocoa Futures Move Down 7 Biggest Price Target Changes For Wednesday Finding Value In Bank ETFs

stock: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

  • [By Lisa Levin] Gainers Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday. Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter. Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday. Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday. Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances. Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral. Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday. Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems. Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend. BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc. Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday. Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

stock: Celldex Therapeutics Inc(CLDX)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.57 percent. Meanwhile, top losers in the sector included Amicus Therapeutics, Inc. (NASDAQ: FOLD), down 9 percent, and Celldex Therapeutics, Inc. (NASDAQ: CLDX), down 9 percent.

  • [By Todd Campbell]

    The ability to develop game-changing new drugs that revolutionize patient care could cause shares in Axovant Sciences (NYSE:AXON), Celldex Therapeutics (NASDAQ:CLDX), and Esperion Therapeutics (NASDAQ:ESPR) to soar. However, success may be tough to come by, and that makes investing in these stocks a boom or bust proposition.

  • [By WWW.KIPLINGER.COM]

    Celldex Therapeutics, Inc. (CLDX) is the first of the major biotech stocks scheduled to release an update on a pretty important drug this quarter; look for news on Oct. 8 concerning melanoma treatment glembatumumab vedotin. And thats a firm date too. Celldex is slated to present an update on the therapy at the European Society for Medical Oncology Congress.

stock: Activision Blizzard, Inc(ATVI)

Advisors’ Opinion:

  • [By Peter Graham]

    In February 2016, King Digital Entertainment PLC (NYSE: KING) was acquired by Activision Blizzard, Inc (NASDAQ: ATVI) for $5.9 billion.

    A technical chart for Glu Mobile shows a November reversal with shares back above a key resistance or support level:

  • [By Brian Feroldi, Chuck Saletta, Tyler Crowe, Jason Hall, and Jordan Wathen]

    With that in mind, we asked a team of Fools each to highlight a stock that a billionaire investor has been selling recently. Read on to see why they chose Cheniere Energy (NYSEMKT:LNG), Activision Blizzard (NASDAQ:ATVI), Suncor Energy (NYSE:SU), MGIC Investment Corporation (NYSE:MTG), and Extended Stay America (NYSE:STAY).

  • [By Demitrios Kalogeropoulos]

    If the stock market is a game, Activision Blizzard (NASDAQ:ATVI) shareholders are winning. The stock is up 60% over the past 12 months (18% in just one day last week) compared to the broader market’s 20% boost.

  • [By Demitrios Kalogeropoulos]

    Activision Blizzard (NASDAQ:ATVI) is set to post earnings results for the key holiday sales period on Thursday, Feb. 9. The stock is trouncing the market over the last five years, but investors have pushed it lower since its last quarterly check-in.

stock: Oshkosh Corporation(OSK)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS). Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

  • [By WWW.THESTREET.COM]

    Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said. 

  • [By Rich Smith]

      I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?

    No. To the contrary, I like it even more. (About $3 more, in fact).

    You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.

    This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.

    So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.

    Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.

stock: Google Inc.(GOOG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Yes, Chipotle is having a great run. It’s gained 27% so far this year, and traded a new 52-week high today. But Chipotle is also expensive–so expensive that the market appears to be treating it like another Amazon.com (AMZN), Tesla (TSLA), Apple (AAPL), or Alphabet (GOOG), Moas wrote in his downgrade today. He explains:

  • [By Daniel Sparks]

    Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) has put its first-quarter earnings release date on the calendar. The internet search giant will report results for its most recently ended quarter on Thursday, April 27. After missing estimates for earnings per share in its most recent quarter, investors will be watching the company’s profitability closely.

  • [By Chris Neiger]

    Or perhaps you’ve heard of a Nest programmable thermostat.Alphabet(NASDAQ:GOOG) (NASDAQ:GOOGL)owns Nest, which makes internet-connected thermostats that you can control via a smartphone or tablet, and learns your heating and cooling preferences the more you use it.

  • [By Daniel Sparks]

    Hastings was careful to emphasize that, unlike Facebook and Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) YouTube, Netflix is a paid service and is not ad supported. But he also noted that Netflix isn’t as entrenched in international markets as these companies.

  • [By Chris Neiger]

    For the mobile side, Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google has already released several iterations of its Cardboard headset, and recently released its new Daydream View headset. These allow users to use their own smartphones to power a VR device.

  • [By Adam Levine-Weinberg]

    Last week, Brand Finance came out with its annual listing of brand valuations. In a somewhat shocking finding, the consulting group declared that Apple (NASDAQ:AAPL) had lost its supremacy to Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) subsidiary Google.

investing in gold

Click to enlarge

The above image is a real picture of a full moon taken in 2012 by an astronaut on board the International Space Station. From blue water to blue sky and the sun revolving earth, there are so many illusions we encounter on a daily basis. I’d like to discuss three illusions in the financial markets that we encounter regularly but hardly take cognizance of.

Illusion 1: A 10% rate of return is always better than a 2% rate of return

Everyone loves a higher rate of return on their investments, and so we believe that if we get a 10% rate of return on an investment, we are better off than when we get a 2% rate of return. It’s a myth and doesn’t always hold good! It’s a classic case of optical illusion in financial markets.

investing in gold: Rex Energy Corporation(REXX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Our peer group is up an average of 46% over the past 4 weeks in response to a 30% rebound in the 12-month strip NYMEX oil price. Some of the largest gainers include Hold and Sell rated stocks that we would not chase such asDenbury Resources (Sell, +138%), Halcon Resources (HK) (Sell, +147%), Jones Energy (JONE) (Hold, +166%), Rex Energy (REXX) (Sell, +60%), Sanchez Energy (SN) (Hold, +93%), Ultra Petroleum (UPL) (Sell, +61%), andWhiting Petroleum (Hold, +103%), which have outperformed the E&P Index (+32%) over the same time period. Balance sheets and/or well level returns remain challenged for these companies despite improved oil prices. While we believe oil markets should re-balance over the next 12 to 15 months, the recent recovery to $40 could reverse during 2Q16 as bloated inventories continue to rise, new volumes from Iran pressure an oversupplied market, and a highly anticipated decline in non-OPEC supply (especially in the U.S.), is not as steep as expected. The risk of an oil price retracement, which would significantly pressure the recent out-performers, outweighs the upside in these stocks, in our view. However, we are raising our target prices on Buy ratedAnadarko Petroleum ($54 from $48), Concho Resources (CXO) ($120 from $109), Matador Resources (MTDR) ($22 from $21),Noble Energy (NBL) ($40 from $34), SM Energy (SM) ($22 from $15), Rice Energy ($14 from $12), Pioneer Natural Resources (PXD) ($155 from $135),Continental Resources ($32 from $28), and Parsley Energy (PE) ($24 from $23). We believe our Buy-rated stocks are better positioned to weather challenging oil markets.

investing in gold: LCA-Vision Inc.(LCAV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Medical Practitioners: This industry jumped 2.82% by 10:15 am. The top performer in this industry was LCA-Vision (NASDAQ: LCAV), which rose 2.9%. LCA-Vision’s trailing-twelve-month revenue is $91.12 million.

investing in gold: Brink's Company (The)(BCO)

Advisors’ Opinion:

  • [By Lee Jackson]

    Another hedge fund that is also a director at Brink’s Co. (NYSE: BCO) was busy selling stock this past week. Starboard parted with a total of 650,000 shares of the security and protection company at prices that fell between $51.47 and $52.05. The total for the sale was set at $34 million. Shares closed on Friday at $52.00. The consensus price target is $56, and the52-week range is $26.86 to $53.90.

  • [By Benzinga News Desk]

    World Wrestling Entertainment (NYSE: WW) received a pair of downgrades after its earnings report came in below estimates.

    Sell-Side's Most Noteworthy Calls Baird downgraded Cardinal Health (NYSE: CAH) to Neutral. Imperial downgraded Brinks (NYSE: BCO) to In-Line. Jefferies upgraded AK Steel (NYSE: AKS) to Buy. Craig-Hallum upgraded LendingClub (NYSE: LC) to Buy. Deal Talk

    General Electric (NYSE: GE) was said to be in talks to acquire Baker Hughes (NYSE: BHI), according to sources as reported by Dow Jones. A deal could be valued at as much as $30 billion. However, Bloomberg later reported that a GE spokesperson said they're in talks with Baker Hughes regarding possible partnerships, but not an acquisition. Halliburton (NYSE: HAL) had attempted to acquire Baker Hughes in 2014, but the DoJ sued to block the deal valued at $35 billion.

investing in gold: CST Brands, Inc.(CST)

Advisors’ Opinion:

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

    American Axle & Manufact. Holdings, Inc. (NYSE: AXL) is expected to report its quarterly earnings at $0.71 per share on revenue of $998.76 million.

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion. CST Brands shares declined 1.20 percent to close at $36.21 on Thursday.

investing in gold: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

investing in gold: Maximus, Inc.(MMS)

Advisors’ Opinion:

  • [By Michael Flannelly]

    Analysts at Jefferies initiated coverage on business process services provider Maximus Inc. (MMS) late on Thursday, giving the stock a bullish rating because it has several competitive advantages and should benefit from the Affordable Care Act (Obamacare).

    The analysts rate MMS as “Buy” and see shares reaching $47. This price target suggests a 20% upside to the stock’s Thursday closing price of $39.14.

    “MMS is a leading government outsourced contractor that produces consistently strong results,” Jefferies analyst David Styblo commented. “The company has several competitive advantages and is highly focused on health and human service projects. This positions MMS to enjoy multi-year growth from the ACA and other opportunities with limited risk. The company’s predictable business model, solid balance sheet, and EPS visibility into FY2014 also support a Buy and $47 PT.”

    Maximus shares were inactive during pre-market trading on Friday. The stock is up 23.83% year-to-date.

top stock buys today

After outperforming the broader markets in 2016, can MSFT stock continue its rally in 2017?

Microsoft Corporation’s (NSDQ:MSFT)stock has been an excellent investment in the last few years. In fact, in 2016, MSFT stock gained 12% while the S&P 500 Index increased by 9.5%, and the Nasdaq Composite Index rose by 7.5%. Moreover, since the beginning of 2012, MSFT stock has gained 139.4%, outperforming the S&P 500 Index, which has increased by 78% and the Nasdaq Composite Index, which has risen 106.6%.

What’s more, the company generates strong cash flow and returns substantial capital to its shareholders through stock buybacks and increasing dividend payments. On September 20, 2016, the company announced an 8% raise in its quarterly dividend to $0.39, or $1.56 a year. The present annual dividend yield is at 2.51%, and the payout ratio is 69.3%. The annual rate of dividend growth over the past three years was very high at 16.1%, over the past five years was also very high at 17.6%, and over the last ten years was high at 15.2%. Also, in its fiscal year 2016, the company bought back $16 billion worth of stock and in the first fiscal quarter of 2017, it repurchased $4 billion worth of its shares. (See also: Microsoft Corporation: Is MSFT Stock A Better Buy Than AAPL Stock Now?)

top stock buys today: iShares Mortgage Real Estate Capped (REM)

Advisors’ Opinion:

  • [By Donald van Deventer]

    The latest implied forward rate forecast from Kamakura Corporation shows projected 10-year U.S. Treasury yields differing -0.07% to 0.03% from last week while fixed rate mortgage yields varied by -0.01% to 0.08%. Mortgage yields, determined by the Monday through Wednesday weekly survey of the Federal Home Loan Mortgage Corporation, lag Treasury movements simply because of the 3-day yield calculation used in the Primary Mortgage Market Survey. The 10-year U.S. Treasury yield is projected to rise from 2.92% at Thursday’s close (down 0.06% from last week) to 3.374% (down 0.06% from last week) in one year. The 10-year U.S. Treasury yield in ten years is forecast to reach 4.639%, 1 basis point lower than last week. The 15-year fixed rate mortgage rate is forecast to rise from the effective yield of 3.69% on Thursday (down 0.001% from last week) to 4.222% (down 0.006% from last week) in one year and 6.29% in 10 years, up 0.038% from last week. We explain the background for these calculations in the rest of this note, along with some mortgage servicing rights metrics. The forecast allows investors in exchange traded U.S. Treasury funds (TLT) (TBT), total return bond funds (BOND), municipal bonds (NUV) and exchange traded mortgage funds (REM) to assess likely total returns over the next 120 months. Treasury-related exchange traded funds affected by the forward rates include:

top stock buys today: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

top stock buys today: Impax Laboratories, Inc.(IPXL)

Advisors’ Opinion:

  • [By Keith Speights]

    Impax Laboratories (NASDAQ: IPXL  ) could be watching more closely than Sanofi. The two companies reached a deal last year that allows Impax to begin marketing a generic version of Renvela in 2014. If approved, Zerenex could take away some of the profits that Impax expected to gain.

top stock buys today: Rave Restaurant Group, Inc.(RAVE)

Advisors’ Opinion:

  • [By Rick Rouse]

    Rouse is sticking with his Best Stocks entry for this year’s competition. His selection is Rave Restaurant Group (RAVE), which owns Pie Five Pizza, a fast-casual pizza joint that Rouse thinks is changing the industry with its unique ovens.

    Says Rouse: “The company is on track to open 500 Pie Five locations over the next few years, and we are still in the early innings of this ballgame.” 

top stock buys today: Tallgrass Energy Partners, LP(TEP)

Advisors’ Opinion:

  • [By Garrett Cook]

    Citi remains Buy rated on Dominion Midstream Partners (NYSE: DM), Tallgrass Energy (NYSE: TEP), and Tallgrass Energy GP (NYSE: TEGP), saying the companies are positioned to capitalize on natural gas demand growth.

stock market game

The New Abenomics Program

The Bank of Japan (BoJ) just launched a new phase in its monetary easing program popularly known as Abenomics. It is doing so in the hopes of shoring up economic growth. This monetary program until today had involved a targeted expansion of the monetary base at 楼80 trillion a year matched by 楼80 trillion in government bond acquisitions. There were also targeted purchases of ETFs and REITs on a smaller scale.1

The new phase unveiled today consists of three key developments. First, the BoJ will target the 10-year government bond interest rate at zero percent. Second, it will aim to overshoot its 2% inflation target so that it is truly symmetric. Third, it will drop its quantity target for the monetary base and simply make its expansion conditional on the inflation overshoot. Everything else in Abenomics remains roughly the same.

So has the Bank of Japan finally mastered its monetary conditions in a way that will spur economic growth? Or is this just another step into the quantitative quagmire of Abenomics? The short answer: do not get your hopes up. There are two reasons why this probably will not make much difference.

stock market game: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

stock market game: 8×8 Inc(EGHT)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Thursday, telecommunications services shares gained by 0.42 percent. Meanwhile, top gainers in the sector included 8×8, Inc. (NASDAQ: EGHT), up 4 percent, and NQ Mobile Inc (ADR) (NYSE: NQ), up 2 percent.

stock market game: Tiffany & Co.(TIF)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q3 2016 earnings report formid cap luxury accessories stock Tiffany & Co (NYSE: TIF) is scheduled for before the market the opens onTuesday (November 29th) as some analystswarn thatthe flagship stores close proximity to Trump Tower could adversely affect sales due to protests and enhanced security in the area. Cowen & Co. Analyst Oliver Chen has warned:

  • [By Lawrence Meyers]

    The finance sector, as mentioned, can make money in many ways. The second-highest growth sector is expected to be consumer discretionary, with a 6.2% increase. When you look at earnings from luxury brands like Tiffany & Co. (TIF), and that the hotel sector continues to do very well, it suggests that those people who are in good financial shape are spending their money. Meanwhile, dollar players like Dollar Tree (DLTR) continue to perform very well, suggesting that folks with less money are spending it on cheaper items.

  • [By Ben Levisohn]

    Cowen’s Oliver Chen and team explain why they named Tiffany (TIF) one of their best ideas for 2017:

    Getty Images

    We are optimistic on Tiffany’s near- and long-term prospects. In the near-term, we have conviction on achievability of FY16 guidance and return to growth in 2017. Our view is that fundamentals will drive EPS upside–specifically, improved momentum in comp store sales through a combination of traffic and unit improvements. As we look to the longer term, our positive view is driven by: (1) modernization of product portfolio towards self-purchase in addition to Tiffany as a gifting destination; (2) category strength in areas such as bridal & engagement jewelry (29% of total revenue mix); (3) Tiffany’s opportunities to leverage its iconic long-term brand equity; (4) substantial barriers to entry with a highly evolved global supply chain, including in-house diamond operations and mining/manufacturing in Botswana; (5) management’s focus on vertical integration through systems/capital investments to advance global procurement, which is expected to gener ate longer-term cost savings; and (6) ample runway to grow e-commerce (online sales currently an est. ~6% of total revenue mix). Factors under Tiffanys control such as better inventory management and an omni-channel program and strategy are also strong positives.

    Shares of Tiffany have risen 0.6% to $84.87.

  • [By Monica Gerson]

    Tiffany & Co. (NYSE: TIF) is estimated to report its quarterly earnings at $0.68 per share on revenue of $914.94 million.

    Costco Wholesale Corporation (NASDAQ: COST) is projected to post its quarterly earnings at $1.22 per share on revenue of $27.09 billion.

  • [By Lisa Levin]

    Tiffany & Co. (NYSE: TIF) reported better-than-expected results for its third quarter.

    Tiffany posted quarterly earnings of $95.1 million, or $0.76 per share, versus earnings of $91 million, or $0.70 per share.

  • [By Ben Levisohn]

    Yesterday, Tiffany (TIF) soared following the release of its earnings. Cowen’s Oliver Chen and team liked what they saw enough to raise their price target but list four things that have to happen before they’d get “more constructive,” which we can only assume means raise their rating:

    Victor J. Blue/Bloomberg News

    We continue to focus our attention on visibility towards 2H improvement and see potential for stock upside as investors gain further confidence on this happening. We look to get constructive on Tiffany if we see: (1) unit performance improving on more newness, particularly in <$500 price points where Tiffany has increased the number of silver jewelry SKUs by double digit percent vs. last year; 2) new marketing driving better engagement performance, which continued to see softness in 2Q; 3) on-going enhancement of in-store experience/customer engagement yielding better traffic/conversion; and 4) store comps improving on easier compares (+7% C/C in 2Q15; +1% C/C in 3Q15; and -5% C/C in 4Q15). We also see potential revenue upside to FY16 guide on retail environment improving in Asia/Hong Kong, U.S. luxury demand re-accelerating; and/or global Chinese spending regaining momentum on less F/X volatility/improving macro environment. Reit. Market Perform with new $74 PT (old $6 8) based on 17x FY17E EPS.

    Shares of Tiffany have ticked up 0.1% to $73.35 at 2:59 p.m. today.

stock market game: Chiasma, Inc.(CHMA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Chiasma Inc (NASDAQ: CHMA) was down, falling around 13 percent to $9.51 ahead of the U.S. Food and Drug Administration’s decision on Friday to approve or reject the company’s therapy. The status of its oral treatment for acromegaly, a capsule known as Mycapssa, will be in focus on Friday. The Street’s biotechnology expert Adam Feuerstein stated that an investor source believes the FDA will reject Chiasma’s capsules because data from a single-arm study failed to demonstrate a clinically meaningful benefit among patients.

stock market game: Progress Software Corporation(PRGS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $93.15 million.

    Sorl Auto Parts, Inc. (NASDAQ: SORL) is expected to post its quarterly earnings at $0.20 per share on revenue of $55.35 million.

  • [By Monica Gerson]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects ConAgra Foods Inc (NYSE: CAG) to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion. ConAgra shares rose 0.17 percent to $47.68 in after-hours trading. Analysts expect Darden Restaurants, Inc. (NYSE: DRI) to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion. Darden Restaurants shares gained 0.44 percent to $66.25 in after-hours trading. Progress Software Corporation (NASDAQ: PRGS) reported better-than-expected results for its second quarter on Wednesday. Progress Software shares surged 6.19 percent to $26.75 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Monica Gerson]

     

    General Mills, Inc. (NYSE: GIS) is expected to report its quarterly earnings at $0.60 per share on revenue of $3.86 billion. Pier 1 Imports Inc (NYSE: PIR) is projected to post a quarterly loss at $0.05 per share on revenue of $420.05 million. Acuity Brands, Inc. (NYSE: AYI) is estimated to report its quarterly earnings at $2.03 per share on revenue of $847.79 million. Monsanto Company (NYSE: MON) is projected to report its quarterly earnings at $2.40 per share on revenue of $4.49 billion. Worthington Industries, Inc. (NYSE: WOR) is expected to report its quarterly earnings at $0.64 per share on revenue of $692.48 million. Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $94.64 million. UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.34 per share on revenue of $366.28 million. Exfo Inc (NASDAQ: EXFO) is expected to post its quarterly earnings at $0.06 per share on revenue of $60.87 million. OMNOVA Solutions Inc. (NYSE: OMN) is projected to report its quarterly earnings at $0.14 per share on revenue of $205.40 million. 8Point3 Energy Partners LP (NASDAQ: CAFD) is estimated to post a quarterly loss at $0.01 per share on revenue of $11.60 million. Park Electrochemical Corp. (NYSE: PKE) is expected to report its quarterly earnings at $0.22 per share on revenue of $35.30 million. Xplore Technologies Corp. (NASDAQ: XPLR) is projected to post its quarterly earnings at $0.01 per share on revenue of $24.00 million. Investors Real Estate Trust (NYSE: IRET) is expected to post its quarterly earnings at $0.14 per share on revenue of $56.87 million. Tel-Instrument Electronics Corp. (NYSE: TIK) is estimated to post earnings for the latest quarter. Aethlon Medical, Inc. (NASDAQ: AEMD) is expected to post a quarterly loss at $0.20 per share. Ossen Innovation Co Ltd (ADR) (NASDAQ: OSN) is projected to post ea

stock market game: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Electronics Stores: This industry moved up 1.16% by 10:15 am. The top performer in this industry was Conns (NASDAQ: CONN), which gained 1.3%. Conns’ PEG ratio is 0.87.

  • [By Lisa Levin]

    Conn’s Inc (NASDAQ: CONN) shares dropped 23 percent to $9.03 as the company reported downbeat quarterly results. Conn’s posted a Q1 loss of $0.31 per share on revenue of $389.1 million.

  • [By Lisa Levin]

    Conn’s Inc (NASDAQ: CONN) shares dropped 24 percent to $8.95 as the company reported downbeat quarterly results. Conn’s posted a Q1 loss of $0.31 per share on revenue of $389.1 million.

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Chris Lange]

    Conn’s Inc. (NASDAQ: CONN) will share its latest quarterly earnings on Thursday. The consensus estimates call for a net loss of $0.07 per share and $413.12 million in revenue. Shares were at $6.84 on Fridays close, in a 52-week range of $6.54 to $34.60. The consensus price target is $13.17.

Top Dividend Stocks To Invest In Right Now

After markets closed on Monday, Boeing Co. (NYSE: BA) announced that it will raise its dividend by 30% and renew its share repurchase program with a $14 billion authorization. The company also said it will cut production of its current model 777 from sevenper month to five beginning in August 2017.

While the dividend hike and share buyback are good news for investors, the production cut to the 777 is less good. It almost certainly means that layoffs will occur, although Boeing did not indicate how many jobs, if any, would be lost.

Then early Tuesday morning, Reuters reported that Farhad Parvaresh, CEO of Iran’s flag carrier Iran Air, announced that Boeing will finance the purchase of the first six airplanes in the deal announced Sunday for 80 new Boeing aircraft. According to the report, Parvaresh said the airline will pay 15% of the cost for the new planes from the country’s development fund.

There are a number of things happening here. First, Boeing is finally admitting that it cannot maintain 777 production at levels that it has for two years insisted were possible. The actual delivery rate of the planes is likely to be 3.5 planes per month, according to Leeham News. The remaining slots on the production line will be “blanks,” the term the company has used to identify gaps in the line that will be filled by Boeing’s transition to the new 777X.

Top Dividend Stocks To Invest In Right Now: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

Top Dividend Stocks To Invest In Right Now: Unifi, Inc.(UFI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Unifi, Inc. (NYSE: UFI) shares were also up, gaining 18 percent to $26.92 as the company announced Q3 earnings of $0.56 per share on revenue of $161.3 million.

Top Dividend Stocks To Invest In Right Now: Public Service Enterprise Group Incorporated(PEG)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Jefferies announced on Tuesday that it has upgraded Public Service Enterprise Group Inc. (PEG).

    The firm has lifted its rating on PEG from “Hold” to “Buy,” and has raised the company’s price target from $36 to $37. This price target suggests a 12% increase from the stock’s current price of $32.42.

    Analyst Paul Fremont commented: “We are upgrading to Buy based on the improving outlook for regulatory approval of the company’s “Energy Strong” capital spending program.

    “Each $1.0 billion of incremental spending will add an estimated $0.10 to PEG’s earnings. We assume that incremental spending is funded by debt and by incremental cash expected from the increasing gas basis differential between the Leidy hub and New Jersey. Our new estimates are considerably higher than consensus in 2014-16.”

    Public Service Enterprise Group shares were mostly flat during pre-market trading Tuesday. The stock is up 6% YTD.